Your browser doesn't support javascript.
loading
Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?
Marini, Bernard L; Perissinotti, Anthony J; Bixby, Dale L; Burke, Patrick W; Pettit, Kristen M; Benitez, Lydia L.
Afiliación
  • Marini BL; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
  • Perissinotti AJ; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
  • Bixby DL; Division of Hematology and Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan.
  • Burke PW; Division of Hematology and Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan.
  • Pettit KM; Division of Hematology and Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan.
  • Benitez LL; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
Cancer ; 125(21): 3890-3891, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31291001
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Inotuzumab Ozogamicina Límite: Humans Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Inotuzumab Ozogamicina Límite: Humans Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article